These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37120067)

  • 21. Prediction of the Oral Pharmacokinetics and Food Effects of Gabapentin Enacarbil Extended-Release Tablets Using Biorelevant Dissolution Tests.
    Yamaguchi Ikeuchi S; Kambayashi A; Kojima H; Oku N; Asai T
    Biol Pharm Bull; 2018; 41(11):1708-1715. PubMed ID: 30381671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of supersaturation level for oral absorption of BCS class IIb drugs, dipyridamole and ketoconazole, using in vivo predictive dissolution system: Gastrointestinal Simulator (GIS).
    Tsume Y; Matsui K; Searls AL; Takeuchi S; Amidon GE; Sun D; Amidon GL
    Eur J Pharm Sci; 2017 May; 102():126-139. PubMed ID: 28263914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance Evaluation of Montelukast Pediatric Formulations: Part I-Age-Related In Vitro Conditions.
    Guimarães M; Somville P; Vertzoni M; Fotaki N
    AAPS J; 2022 Jan; 24(1):26. PubMed ID: 35013835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Instrumentation of Flow-Through USP IV Dissolution Apparatus to Assess Poorly Soluble Basic Drug Products: a Technical Note.
    Paprskářová A; Možná P; Oga EF; Elhissi A; Alhnan MA
    AAPS PharmSciTech; 2016 Oct; 17(5):1261-6. PubMed ID: 26573157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of UV Imaging in Formulation Development.
    Sun Y; Østergaard J
    Pharm Res; 2017 May; 34(5):929-940. PubMed ID: 27766463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydrodynamics-induced variability in the USP apparatus II dissolution test.
    Baxter JL; Kukura J; Muzzio FJ
    Int J Pharm; 2005 Mar; 292(1-2):17-28. PubMed ID: 15725550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a biphasic dissolution test for Deferasirox dispersible tablets and its application in establishing an in vitro-in vivo correlation.
    Al Durdunji A; AlKhatib HS; Al-Ghazawi M
    Eur J Pharm Biopharm; 2016 May; 102():9-18. PubMed ID: 26898545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Developing dissolution testing methodologies for extended-release oral dosage forms with supersaturating properties. Case example: Solid dispersion matrix of indomethacin.
    Tajiri T; Morita S; Sakamoto R; Mimura H; Ozaki Y; Reppas C; Kitamura S
    Int J Pharm; 2015 Jul; 490(1-2):368-74. PubMed ID: 26022889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Dissolution Medium pH and Simulated Gastrointestinal Contraction on Drug Release From Nifedipine Extended-Release Tablets.
    Gao Z; Ngo C; Ye W; Rodriguez JD; Keire D; Sun D; Wen H; Jiang W
    J Pharm Sci; 2019 Mar; 108(3):1189-1194. PubMed ID: 30343136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissolution testing of powders for inhalation: influence of particle deposition and modeling of dissolution profiles.
    May S; Jensen B; Weiler C; Wolkenhauer M; Schneider M; Lehr CM
    Pharm Res; 2014 Nov; 31(11):3211-24. PubMed ID: 24852894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of an artificial intelligence-based assessment model for prediction of embryo viability using static images captured by optical light microscopy during IVF.
    VerMilyea M; Hall JMM; Diakiw SM; Johnston A; Nguyen T; Perugini D; Miller A; Picou A; Murphy AP; Perugini M
    Hum Reprod; 2020 Apr; 35(4):770-784. PubMed ID: 32240301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Coadministered Water on the In Vivo Performance of Oral Formulations Containing N-Acetylcysteine: An In Vitro Approach Using the Dynamic Open Flow-Through Test Apparatus.
    Sager M; Schneider F; Jedamzik P; Wiedmann M; Schremmer E; Koziolek M; Weitschies W
    Mol Pharm; 2017 Dec; 14(12):4272-4280. PubMed ID: 29064257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanistic modelling and mechanistic monitoring: simulation and shadowgraph imaging of particulate dissolution in the flow-through apparatus.
    D'arcy DM; Persoons T
    J Pharm Sci; 2011 Mar; 100(3):1102-15. PubMed ID: 20848646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and application of a biorelevant dissolution method using USP apparatus 4 in early phase formulation development.
    Fang JB; Robertson VK; Rawat A; Flick T; Tang ZJ; Cauchon NS; McElvain JS
    Mol Pharm; 2010 Oct; 7(5):1466-77. PubMed ID: 20701327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of different screening methods to understand the dissolution behaviors of amorphous solid dispersions.
    Lee TW; Boersen NA; Yang G; Hui HW
    Drug Dev Ind Pharm; 2014 Aug; 40(8):1072-83. PubMed ID: 23802148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydrodynamic investigation of USP dissolution test apparatus II.
    Bai G; Armenante PM; Plank RV; Gentzler M; Ford K; Harmon P
    J Pharm Sci; 2007 Sep; 96(9):2327-49. PubMed ID: 17573698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Velocity Field Visualization in USP Dissolution Apparatus 3 Using Particle Image Velocimetry.
    Perivilli S; Prevost R; Stippler E
    Pharm Res; 2017 Jun; 34(6):1330-1337. PubMed ID: 28409325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Commentary on AAPS Workshop: dissolution testing for the twenty-first century: linking critical quality attributes and critical process parameters to clinically relevant dissolution.
    Tong C; D'Souza SS; Parker JE; Mirza T
    Pharm Res; 2007 Sep; 24(9):1603-7. PubMed ID: 17385013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perspective on a chemistry classification system for AI-assisted formulation development.
    Bolger MB
    J Control Release; 2022 Dec; 352():833-839. PubMed ID: 36334857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DeepFundus: A flow-cytometry-like image quality classifier for boosting the whole life cycle of medical artificial intelligence.
    Liu L; Wu X; Lin D; Zhao L; Li M; Yun D; Lin Z; Pang J; Li L; Wu Y; Lai W; Xiao W; Shang Y; Feng W; Tan X; Li Q; Liu S; Lin X; Sun J; Zhao Y; Yang X; Ye Q; Zhong Y; Huang X; He Y; Fu Z; Xiang Y; Zhang L; Zhao M; Qu J; Xu F; Lu P; Li J; Xu F; Wei W; Dong L; Dai G; He X; Yan W; Zhu Q; Lu L; Zhang J; Zhou W; Meng X; Li S; Shen M; Jiang Q; Chen N; Zhou X; Li M; Wang Y; Zou H; Zhong H; Yang W; Shou W; Zhong X; Yang Z; Ding L; Hu Y; Tan G; He W; Zhao X; Chen Y; Liu Y; Lin H
    Cell Rep Med; 2023 Feb; 4(2):100912. PubMed ID: 36669488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.